Biomedical Engineering Reference
In-Depth Information
[118] Ahn BN , Kim SK , Shim CK . Preparation and evaluation of proliposomes containing
propranolol hydrochloride . J Microencapsulation 1995 ; 12 : 363 - 75 .
[119] Torchilin VP . Structure and design of polymeric surfactant-based drug delivery systems .
J Control Release 2001 ; 73 : 137 - 72 .
[120] Tengamnuay P , Mitra AK . Bile salt - fatty acid mixed micelles as nasal absorption pro-
moters of peptides. I. Effects of ionic strength, adjuvant composition, and lipid structure
on the nasal absorption of [
D
-Arg2]kyotorphin . Pharm Res 1990 ; 7 : 127 - 33 .
[121] Jain R , Nabar S , Dandekar P , Patravale V . Micellar nanocarriers: potential nose-to-brain
delivery of zolmitriptan as novel migraine therapy . Pharma Res 2010 ; 27 : 655 - 6 4 .
[122] Bradbury MW , Cserr HF , Westrop RJ . Drainage of cerebral interstitial fluid into deep
cervical lymph of the rabbit . Am J Physiol 1981 ; 240 : F329 - 36 .
[123] Eppstein DA , Longenecker JP . Alternative delivery systems for peptides and proteins as
drugs . Crit Rev Ther Drug Carrier Syst 1988 ; 5 : 99 - 139 .
[124] Wearley LL . Recent progress in protein and peptide delivery by noninvasive routes . Crit
Rev Ther Drug Carrier Syst 1991 ; 8 : 331 - 94 .
[125] Lee VHL , Yamamoto A , Kompella UB . Mucosal penetration enhancers for facilitation
of peptide and protein drug absorption . Crit Rev Ther Drug Carrier Syst 1991 ; 8 : 91 - 192 .
[126] Adjei AL . Clinical development of inhaled peptides and proteins . In: Adjei AL , Gupta
PK , editors. Inhalation delivery of therapeutic peptides and proteins . New York : Marcel
Dekker ; 1997 . p. 771 - 814 .
[127] Byron PR . Determinants of drug and polypeptide bioavailability from aerosols deliv-
ered to the lung . Adv Drug Deliv Rev 1990 ; 5 : 107 - 32 .
[128] Patton JS . Mechanisms of macromolecule absorption by the lungs . Adv Drug Deliv Rev
1996 ; 19 : 3 - 36 .
[129] Folkesson HG , Westrom BR , Karlsson BW . Permeability of the respiratory tract to dif-
ferent-sized macromolecules after intratracheal instillation in young and adult rats .
Acta Physiol Scand 1990 ; 139 : 347 - 54 .
[130] Folkesson HG , Westrom BR , Dahlback M , Lundin S , Karlsson BW . Passage of aerosol-
ized BSA and the nona-peptide dDAVP, via the respiratory tract in young and adult rats
.
Exp Lung Res 1992 ; 18 : 595 - 614 .
[131] Adjei A , Hui J , XFinely R , Lin T , Lancaster J , Fort F . Pulmonary bioavailability of leu-
prolide acetate following multiple dosing to beagle dogs: some pharmacokinetic and
preclinical issues . Int J Pharm 1994 ; 107 : 57 - 66 .
[132] Gautam
A ,
Waldrep
JC ,
Densmore
CL .
Aerosol
gene
therapy .
Mol
Biotechnol
2003 ; 23 : 51 - 60 .
[133] Brain DB , Valberg PA , Sneddon S . Mechanisms of aerosol deposition and clearance . In:
Moren F , Newhouse MT , Dolovich MB , editors. Aerosols in medicine, principles, diag-
nostics and therapy (Chapter 5) . New York, NY : Elsevier ; 1985 .
[134] Allison AC , Harrington JS , Birbeck M . An examination of the cytotoxic effects of silica
on macrophages . J Exp Med 1966 ; 124 : 141 - 54 .
[135] Bowden
DH .
Macrophages,
dust,
and
pulmonary
diseases .
Exp
Lung
Res
1987 ; 12 : 89 - 107 .
[136] Niven RW . Delivery of biotherapeutics by inhalation aerosol . Crit Rev Ther Drug Carrier
Syst 1995 ; 12 : 151 - 231 .
[137] Huang YY , Wang CH . Pulmonary delivery of insulin by liposomal carriers . J Controlled
Release 2006 ; 113 : 9 - 14 .
[138] Grossman J . The evolution of inhaler technology
. J Asthma 1993 ; 31 : 55 - 64 .
[139] Far SJ , McElduff A , Ward E , Okumu F , Mather L , Gonda I
. A comparison of pharma-
cokinetics and pharmacodynamics of inhaled insulin administered as different strength
solutions to healthy volunteers . J Am Diabetes Assoc 1998 ; 47 : A61 .
Search WWH ::
Custom Search